Medicine
Eletriptan 20 mg tablet
Eletriptan 20 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Eletriptan
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 1000 tablets, 10 blister pack and 10 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaApnar PharmaMylan PharmaceuticalsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N02CC06 Eletriptan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 July 2017
- Identifiers
- RxCUI 359493, 359494DailyMed set ID 62dc12ce-4f19-41c6-9593-3cae29f04af1, 481ae7d4-9e57-424a-9d07-2920954b6ddc, 6d412c0d-c8bd-498d-b57c-6626fb33147a +4NDC 0093-8310, 70771-1107, 31722-443 +4Application ANDA202040, ANDA206409, ANDA219143 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 68382-922-06 | Zydus LifesciencesIndia | 12 July 2017 |
| 1000 tablet, film coated in 1 bottle | 68382-922-10 | Zydus LifesciencesIndia | 12 July 2017 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 68382-922-77 | Zydus LifesciencesIndia | 12 July 2017 |
| 1 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 68382-922-86 | Zydus LifesciencesIndia | 12 July 2017 |
| 1000 tablet, film coated in 1 bottle | 70771-1107-0 | Zydus LifesciencesIndia | 12 July 2017 |
| 30 tablet, film coated in 1 bottle | 70771-1107-3 | Zydus LifesciencesIndia | 12 July 2017 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 70771-1107-4 | Zydus LifesciencesIndia | 12 July 2017 |
| 1 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 70771-1107-6 | Zydus LifesciencesIndia | 12 July 2017 |
| 1 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 59651-104-69 | Aurobindo PharmaIndia | 15 January 2019 |
| 1 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 31722-443-31 | Camber PharmaceuticalsIndia | 7 July 2025 |
| 100 tablet, film coated in 1 bottle | 24689-167-01 | Apnar Pharma | 13 May 2026 |
| 1 blister pack in 1 carton / 6 tablet, film coated in 1 blister pack | 0378-4287-85 | Mylan Pharmaceuticals | 15 August 2017 |
| 6 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0093-8310-18 | Teva Pharmaceuticals | 21 July 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 26 December 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Eletriptan 20 mg tablet.
Other strengths and forms of Eletriptan
Clinical summary
Eletriptan is a serotonin-1b and serotonin-1d receptor agonist indicated for the acute treatment of migraine with or without aura in adults, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Eletriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EletriptanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Relpax prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Eletriptan 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.